DrugPatentWatch Database Preview
ALECENSA Drug Profile
Which patents cover Alecensa, and when can generic versions of Alecensa launch?
This drug has sixty-five patent family members in thirty-six countries.
The generic ingredient in ALECENSA is alectinib hydrochloride. One supplier is listed for this compound. Additional details are available on the alectinib hydrochloride profile page.
Summary for ALECENSA
| International Patents: | 65 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 79 |
| Clinical Trials: | 5 |
| Patent Applications: | 5 |
| Drug Prices: | see details |
| DailyMed Link: | ALECENSA at DailyMed |
Pharmacology for ALECENSA
| Drug Class | Kinase Inhibitor |
| Mechanism of Action | Kinase Inhibitors |
Synonyms for ALECENSA
| 1256589-74-8 |
| 3341AH |
| 5H-Benzo[B]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-ipperidinyl]-11-oxo-, hydrochloride (1:1) |
| 9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride (1:1) |
| 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt |
| 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride |
| ACN-050755 |
| AF-802 hydrochloride |
| AGN-PC-09O9BF |
| AK174941 |
| AKOS025404940 |
| Alecensa (TN) |
| Alectinib Hydrochloride |
| Alectinib hydrochloride (JAN) |
| Alectinib Hydrochloride;AF-802 Hydrochloride;CH-5424802 Hydrochloride;RG-7853 Hydrochloride;RO-5424802 Hydrochloride |
| alectinib monohydrochloride |
| AOB87772 |
| AS-17062 |
| C30H34N4O2.ClH |
| CH 5424802, Alectinib HCl |
| CH5424802 (Hydrochloride) |
| CH5424802 HCl |
| CH5424802 HCl (AF 802 HCl, Alectinib HCl) |
| CH5424802 HCl salt, Alectinib HCl salt, AF802 HCl salt |
| CH5424802 Hydrochloride |
| CH5424802(Hydrochloride) |
| CHEBI:62268 |
| CHEMBL3707320 |
| CS-3480 |
| D10450 |
| DTXSID10154841 |
| EX-A1553 |
| GYABBVHSRIHYJR-UHFFFAOYSA-N |
| HY-13011A |
| KS-00001D3B |
| MFCD27987893 |
| MolPort-039-137-749 |
| P9YY73LO6J |
| SCHEMBL14991271 |
| UNII-P9YY73LO6J |
US Patents and Regulatory Information for ALECENSA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Hoffmann-la Roche | ALECENSA | alectinib hydrochloride | CAPSULE;ORAL | 208434-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for ALECENSA
Supplementary Protection Certificates for ALECENSA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017 00024 | Denmark | ➤ Sign Up | PRODUCT NAME: ALECTINIB, ELLER SALT ELLER SOLVAT DERAF, HERUNDER I FORM AF HYDROCHLORID; REG. NO/DATE: EU/1/16/1169/01 20170220 |
| 0876 | Netherlands | ➤ Sign Up | PRODUCT NAME: ALECTINIB DAN WEL EEN ZOUT OF SOLVAAT DAARVAN; REGISTRATION NO/DATE: EU/1/16/1169/001 20170220 |
| 2017017 | Lithuania | ➤ Sign Up | PRODUCT NAME: ALEKTINIBAS ARBA JO DRUSKA, ARBA SOLVATAS; REGISTRATION NO/DATE: EU/1/16/1169 20170216 |
| 2017000048 | Germany | ➤ Sign Up | PRODUCT NAME: ALECTINIB ODER EIN SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/16/1169 20170216 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
